Literature DB >> 6683815

Pharmacology of cranial dystonia.

C D Marsden, A E Lang, M P Sheehy.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6683815     DOI： 10.1212/wnl.33.8.1100

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Blepharospasm and Hemifacial Spasm.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.598

Review 2.  Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.

Authors:  S P Kraft; A E Lang
Journal:  CMAJ       Date:  1988-11-01       Impact factor: 8.262

3.  Blepharospasm: a review of 264 patients.

Authors:  F Grandas; J Elston; N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

4.  Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases.

Authors:  S Maurri; S Brogelli; G Alfieri; F Barontini
Journal:  Ital J Neurol Sci       Date:  1988-08

5.  Dopamine Receptor Agonist Treatment of Idiopathic Dystonia: A Reappraisal in Humans and Mice.

Authors:  Xueliang Fan; Yuping Donsante; H A Jinnah; Ellen J Hess
Journal:  J Pharmacol Exp Ther       Date:  2018-01-18       Impact factor: 4.030
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.